Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Colorectal Neoplasms

Free Subscription 25.05.2020 2 BMC Cancer 2 Br J Cancer 1 Clin Cancer Res 2 Int J Cancer 1 Int J Colorectal Dis 1 J Natl Cancer Inst 1 Lancet Gastroenterol Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. EYL RE, Thong MSY, Carr PR, Jansen L, et al
   Physical activity and long-term fatigue among colorectal cancer survivors - a population-based prospective study.
   BMC Cancer. 2020;20:438.
   PubMed         Abstract available
   
   
2. SUN Y, Cao B, Zhou J
   Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.
   BMC Cancer. 2020;20:434.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. WANG K, Song K, Ma Z, Yao Y, et al
   Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
   Br J Cancer. 2020 May 21. pii: 10.1038/s41416-020-0902.
   PubMed         Abstract available
   
   
4. FUCA G, Guarini V, Antoniotti C, Morano F, et al
   The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
   Br J Cancer. 2020 May 19. pii: 10.1038/s41416-020-0894.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. MCCUAIG S, Barras D, Mann E, Friedrich M, et al
   The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer.
   Clin Cancer Res. 2020 May 19. pii: 1078-0432.CCR-19-1086.
   PubMed         Abstract available
   
   

   
   Int J Cancer

6. KIM N, Cho D, Kim H, Kim S, et al
   Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.
   Int J Cancer. 2020;146:2194-2200.
   PubMed         Abstract available
   
   
7. TOLBA MF
   Revolutionizing the Landscape of Colorectal Cancer Treatment: The Potential Role of Immune Checkpoint Inhibitors.
   Int J Cancer. 2020 May 16. doi: 10.1002/ijc.33056.
   PubMed         Abstract available
   
   

   
   Int J Colorectal Dis

8. HAN L, Dai W, Mo S, Xiang W, et al
   Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a population-based real-world analysis.
   Int J Colorectal Dis. 2020 May 16. pii: 10.1007/s00384-020-03612.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

9. ZAANAN A, Henriques J, Cohen R, Sefrioui D, et al
   Efficacy of anti-EGFR in MSI metastatic colorectal cancer depending on sporadic or familial origin.
   J Natl Cancer Inst. 2020 May 16. pii: 5838189. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Lancet Gastroenterol Hepatol

10. LIANG PS, Shaukat A
    Assessing the impact of lowering the colorectal cancer screening age to 45 years.
    Lancet Gastroenterol Hepatol. 2020;5:523-524.
    PubMed        
    
    

    
    PLoS One

11. TAYLOR WS, Pearson J, Miller A, Schmeier S, et al
    MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
    PLoS One. 2020;15:e0233170.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: